Skorpios Trust, 10% Owner at Stoke Therapeutics, Inc. (STOK), sold 6,000,000 shares at $10.20 ($61.2M) on 2025-06-04, disclosed to the SEC on 2025-06-06.
Open-market sale of $61.2M STOK by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.20 | 3,000,000 | $30.6M | 50.0% |
| 2 | $10.20 | 3,000,000 | $30.6M | 50.0% |
| Total | $10.20 avg | 6,000,000 | $61.2M | 100% |